David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Ingersoll Rand
IR
$30.5B
| $10.9M | 0.01% |
390,514
+31,600
| +9% | +$795K |
|
1027
CALL
Kraft Heinz
KHC
$30B
| $10.9M | 0.01% |
332,500
+85,000
| +34% | +$3.46M |
|
|
ACC
1028
DELISTED
American Campus Communities, Inc.
ACC
| $10.8M | 0.01% |
227,694
-211,923
| -48% | -$9.53M |
|
|
COWN
1029
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $10.8M | 0.01% |
746,510
+369,840
| +98% | +$5.65M |
|
|
ZIXI
1030
DELISTED
Zix Corporation
ZIXI
| $10.8M | 0.01% |
1,569,915
-38,209
| -2% | -$273K |
|
|
GLDD
1031
DELISTED
Great Lakes Dredge & Dock
GLDD
| $10.8M | 0.01% |
1,209,304
+248,035
| +26% | +$1.93M |
|
|
INFN
1032
DELISTED
Infinera Corporation Common Stock
INFN
| $10.8M | 0.01% |
2,482,698
+974,328
| +65% | +$4.49M |
|
1033
Healthcare Services Group
HCSG
$1.57B
| $10.8M | 0.01% |
+326,481
| New | +$12.5M |
|
1034
Hubbell
HUBB
$24.5B
| $10.8M | 0.01% |
91,156
-120,901
| -57% | -$13.7M |
|
1035
Weibo
WB
$1.75B
| $10.7M | 0.01% |
173,058
+10,178
| +6% | +$632K |
|
1036
Pacific Biosciences
PACB
$472M
| $10.7M | 0.01% |
1,479,032
-620,801
| -30% | -$4.49M |
|
|
TLND
1037
DELISTED
Talend S.A. American Depositary Shares
TLND
| $10.6M | 0.01% |
210,380
+191,136
| +993% | +$8.16M |
|
1038
CALL
TransDigm Group
TDG
$65.9B
| $10.6M | 0.01% |
23,400
-56,200
| -71% | -$22.8M |
|
|
AIV
1039
Aimco
AIV
$375M
| $10.6M | 0.01% |
1,583,328
-3,579,552
| -69% | -$23.1M |
|
|
BOLD
1040
DELISTED
Audentes Therapeutics, Inc
BOLD
| $10.6M | 0.01% |
271,191
+131,550
| +94% | +$3.77M |
|
|
GPOR
1041
DELISTED
Gulfport Energy Corp.
GPOR
| $10.6M | 0.01% |
1,316,710
-514,749
| -28% | -$4.1M |
|
1042
PUT
MongoDB
MDB
$32.6B
| $10.6M | 0.01% |
71,800
+45,000
| +168% | +$4.62M |
|
|
STL
1043
DELISTED
Sterling Bancorp
STL
| $10.6M | 0.01% |
566,530
+392,494
| +226% | +$7.5M |
|
|
HEXO
1044
DELISTED
HEXO Corp. Common Shares
HEXO
| $10.6M | 0.01% |
+28,493
| New | +$9.23M |
|
|
FTV.PRA
1045
DELISTED
Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A
FTV.PRA
| $10.5M | 0.01% |
10,000
| – | – |
|
|
SHOE
1046
Shoe Station Group
SHOE
$389M
| $10.5M | 0.01% |
618,950
+267,828
| +76% | +$4.87M |
|
1047
Editas Medicine
EDIT
$504M
| $10.5M | 0.01% |
430,300
-36,747
| -8% | -$832K |
|
1048
CALL
Blackrock
BLK
$182B
| $10.5M | 0.01% |
24,600
-14,700
| -37% | -$6.17M |
|
1049
PUT
Thor Industries
THO
$4.14B
| $10.5M | 0.01% |
168,000
+26,600
| +19% | +$1.68M |
|
1050
Labcorp
LH
$27.4B
| $10.4M | 0.01% |
79,301
+45,748
| +136% | +$5.64M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.